Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report.

Literature DB >> 19529909

Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report.

Francesco G De Rosa¹, Pierpaolo Terragni, Daniela Pasero, Anna C Trompeo, Rosario Urbino, Anna Barbui, Giovanni Di Perri, V Marco Ranieri.

Abstract

Entities: Disease

Mesh：

Substances：
Antifungal Agents

Year: 2009 PMID： 19529909 DOI： 10.1007/s00134-009-1546-9

Source DB: PubMed Journal: Intensive Care Med ISSN： 0342-4642 Impact factor: 17.440

× No keyword cloud information.

15 in total

1. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

Authors: Johan Maertens; Issam Raad; George Petrikkos; Marc Boogaerts; Dominik Selleslag; Finn B Petersen; Carole A Sable; Nicholas A Kartsonis; Angela Ngai; Arlene Taylor; Thomas F Patterson; David W Denning; Thomas J Walsh
Journal: Clin Infect Dis Date: 2004-11-09 Impact factor: 9.079

2. Comparison of clinical and post-mortem findings in intensive care unit patients.

Authors: Calliope Maris; Benoît Martin; Jacques Creteur; Myriam Remmelink; Michael Piagnerelli; Isabelle Salmon; Jean-Louis Vincent; Pieter Demetter
Journal: Virchows Arch Date: 2007-01-25 Impact factor: 4.064

3. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors: Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal: Clin Infect Dis Date: 2008-02-01 Impact factor: 9.079

4. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.

Authors: Edward Sionov; Sonia Mendlovic; Esther Segal
Journal: J Infect Date: 2005-12-19 Impact factor: 6.072

Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report.

1. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

2. Comparison of clinical and post-mortem findings in intensive care unit patients.

3. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

4. Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis.

5. Pseudomembranous and obstructive Aspergillus tracheobronchitis - optimal diagnostic strategy and outcome.

6. Pseudomembranous tracheobronchitis caused by Aspergillus in immunocompromised patients.

7. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans.

8. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.

9. Continuous and 4 h infusion of amphotericin B: a comparative study involving high-risk haematology patients.

Review 10. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients.

Review 1. Tracheobronchial manifestations of Aspergillus infections.

2. Invasive pulmonary aspergillosis after influenza a infection in an immunocompetent patient.